QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Vol. 20, Issue 12, 2963-2978, June 15, 2009

This Article Full Text Full Text (PDF) Supplemental Materials All Versions of this Article: E08-12-1251v1 20/12/2963    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Ackermann, M. A. Articles by Kontrogianni-Konstantopoulos, A. Search for Related Content PubMed PubMed Citation Articles by Ackermann, M. A. Articles by Kontrogianni-Konstantopoulos, A.

Obscurin Interacts with a Novel Isoform of MyBP-C Slow at the Periphery of the Sarcomeric M-Band and Regulates Thick Filament Assembly

Maegen A. Ackermann^*, Li-Yen R. Hu^*,, Amber L. Bowman^,, Robert J. Bloch, and Aikaterini Kontrogianni-Konstantopoulos^*

Departments of *Biochemistry and Molecular Biology and Physiology, University of Maryland School of Medicine, Baltimore, MD 21201

Submitted December 30, 2008; Revised April 13, 2009; Accepted April 16, 2009
Monitoring Editor: M. Bishr Omary

Obscurin is a multidomain protein composed of adhesion and signaling domains that plays key roles in the organization of contractile and membrane structures in striated muscles. Overexpression of the second immunoglobulin domain of obscurin (Ig2) in developing myotubes inhibits the assembly of A- and M-bands, but not Z-disks or I-bands. This effect is mediated by the direct interaction of the Ig2 domain of obscurin with a novel isoform of myosin binding protein-C slow (MyBP-C slow), corresponding to variant-1. Variant-1 contains all the structural motifs present in the known forms of MyBP-C slow, but it has a unique COOH terminus. Quantitative reverse transcription-polymerase chain reaction indicated that MyBP-C slow variant-1 is expressed in skeletal muscles both during development and at maturity. Immunolabeling of skeletal myofibers with antibodies to the unique COOH terminus of variant-1 demonstrated that, unlike other forms of MyBP-C slow that reside in the C-zones of A-bands, variant-1 preferentially concentrates around M-bands, where it codistributes with obscurin. Overexpression of the Ig2 domain of obscurin or reduction of expression of obscurin inhibited the integration of variant-1 into forming M-bands in skeletal myotubes. Collectively, our experiments identify a new ligand of obscurin at the M-band, MyBP-C slow variant-1 and suggest that their interaction contributes to the assembly of M- and A-bands.

These authors contributed equally to this work.

Address correspondence to: Aikaterini Kontrogianni-Konstantopoulos (akons001{at}umaryland.edu)